Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Kester Kent Edward — TETRAGENEX PHARMACEUTICALS, INC. insider: 2 transactions · InsiderLens

Home / Insiders / Kester Kent Edward

Kester Kent Edward

Director at TETRAGENEX PHARMACEUTICALS, INC. · on record since Jun 8, 2026

Insider trading activity of Kester Kent Edward

Transactions on record: 2; since Oct 10, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 8, 2026

Figures computed from official regulatory filings — methodology.

Companies where Kester Kent Edward has traded

TETRAGENEX PHARMACEUTICALS, INC.2 tx · Jun 8, 2026

Track record of Kester Kent Edward

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kester Kent Edward

Co-insiders of Kester Kent Edward

Abel DavidTETRAGENEX PHARMACEUTICALS, INC.
Akerman Alf E FTETRAGENEX PHARMACEUTICALS, INC.
BEB Holdings, LLCTETRAGENEX PHARMACEUTICALS, INC.
Bergman Bruce JTETRAGENEX PHARMACEUTICALS, INC.
Budetti Robert PeterTETRAGENEX PHARMACEUTICALS, INC.
Burnam Bradley EvanTETRAGENEX PHARMACEUTICALS, INC.
Cartwright KennethTETRAGENEX PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Chaudhary ZuraizTETRAGENEX PHARMACEUTICALS, INC.

Chesed AbrahamTETRAGENEX PHARMACEUTICALS, INC.

COHEN AARONTETRAGENEX PHARMACEUTICALS, INC.

COMER WILLIAM TTETRAGENEX PHARMACEUTICALS, INC.

Dewhurst Martin WilliamTETRAGENEX PHARMACEUTICALS, INC.

Gengos AndrewTETRAGENEX PHARMACEUTICALS, INC.

Ghodadra Neilesh ShaileshTETRAGENEX PHARMACEUTICALS, INC.

GOLDEN ARTHUR FTETRAGENEX PHARMACEUTICALS, INC.

Hamlin John W JRTETRAGENEX PHARMACEUTICALS, INC.

Martucci NeilTETRAGENEX PHARMACEUTICALS, INC.

SCHACKER MARTIN FTETRAGENEX PHARMACEUTICALS, INC.

SHENK WILLIAM ATETRAGENEX PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
TETRAGENEX PHARMACEUTICALS, INC.	Jun 8, 2026	AwardD	83,334	0.00 USD	$0	SEC
TETRAGENEX PHARMACEUTICALS, INC.	Oct 10, 2025	Award	10,000	0.00 USD	$0	SEC